NASDAQ: KYMR
Kymera Therapeutics Inc Stock Ownership - Who owns Kymera Therapeutics?

Insider buying vs selling

Have Kymera Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Baker Bros Advisors LPDirector2025-06-3055,191$44.00
$2.43MBuy
Baker Bros Advisors LPDirector2025-06-30600,309$44.00
$26.41MBuy
Bvf Partners L PDirector2025-06-3058,780$44.00
$2.59MBuy
Bvf Partners L PDirector2025-06-30142,604$44.00
$6.27MBuy
Bvf Partners L PDirector2025-06-30115,783$44.00
$5.09MBuy
Elena RidloffDirector2025-06-114,500$50.00
$225.00kSell
Elena RidloffDirector2025-06-114,500$20.29
$91.31kBuy
Nello MainolfiChief Executive Officer2025-06-0330,000$49.00
$1.47MSell
Pamela EspositoDirector2025-06-035,000$49.04
$245.19kSell
Pamela EspositoDirector2025-06-035,000$29.55
$147.75kBuy

1 of 5

KYMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYMR insiders and whales buy or sell their stock.

KYMR Shareholders

What type of owners hold Kymera Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Price T Rowe Associates Inc10.29%6,702,450$302.82MInstitution
Avoro Capital Advisors LLC9.92%6,460,000$291.86MInstitution
Baker Bros Advisors LP9.39%6,117,295$276.38MInsider
Wellington Management Group LLP9.21%5,996,873$270.94MInstitution
Baker Bros Advisors LP9.21%5,995,929$270.90MInstitution
Atlas Venture Associates X LP8.85%5,763,012$260.37MInsider
Atlas Venture Fund X LP8.45%5,504,905$248.71MInsider
Vanguard Group Inc8.03%5,231,392$236.35MInstitution
Bvf Inc7.93%5,161,801$233.21MInstitution
Atlas Venture Life Science Advisors LLC7.52%4,896,462$221.22MInstitution

1 of 3

KYMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYMR74.53%25.47%Net BuyingNet Buying
RARE84.71%15.29%Net SellingNet Selling
IMVT47.98%52.02%Net BuyingNet Selling
CRNX88.82%11.18%Net BuyingNet Selling
MLTX72.50%27.50%Net SellingNet Selling

Kymera Therapeutics Stock Ownership FAQ

Who owns Kymera Therapeutics?

Kymera Therapeutics (NASDAQ: KYMR) is owned by 111.81% institutional shareholders, 38.21% Kymera Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Kymera Therapeutics shareholder, owning 6.12M shares representing 9.39% of the company. Baker Bros Advisors LP's Kymera Therapeutics shares are currently valued at $276.56M.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.